Nanfang Hospital

Researchers

• CWChangjie Wu
• YHYanfeng Hu

Running trials

• Not yet recruiting

  Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

  NCT06136507· Phase 3· Hangzhou Gensciences Biopharmaceutical Co., Ltd.· Source

• Recruiting

  Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy

  NCT07789184· Phase 3· Hua Huang, MD, PhD· Source

• Recruiting

  Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure

  NCT07575672· Phase 3· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source

• Recruiting

  Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07871110· Phase 2· TransThera Sciences (Nanjing), Inc.· Source

• Recruiting

  Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT07687459· Phase 3· InSilico Medicine Hong Kong Limited· Source

• Not yet recruiting

  De-escalation Strategy of Tyrosine Kinase Inhibitors Before Treatment Discontinuation in Patients With Chronic Myeloid Leukemia

  NCT07839988· Phase 4· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL

  NCT07831395· Phase 2· Institute of Hematology & Blood Diseases Hospital, China· Source

• Not yet recruiting

  Self-Management Support for Acute Coronary Syndrome Patients After Hospital Discharge

  NCT07799376· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study

  NCT07762573· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy

  NCT07091994· Phase 4· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

  NCT07606950· Phase 3· Fujian Shengdi Pharmaceutical Co., Ltd.· Source

• Recruiting

  PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract

  NCT07700498· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke

  NCT07604298· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease

  NCT07667517· Phase 4· First Affiliated Hospital of Zhejiang University· Source

• Recruiting

  Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

  NCT07555938· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy

  NCT07604311· Phase 4· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

  NCT07579949· Phase 2· ScinnoHub Pharmaceutical Co., Ltd.· Source

• Recruiting

  SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

  NCT07710248· Phase 2· Hangzhou Sumgen Biotech Co., Ltd.· Source

• Recruiting

  Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

  NCT07744087· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases

  NCT07539753· Phase 2· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma

  NCT07603349· Phase 2/3· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer

  NCT07511894· Phase 2· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation

  NCT07608120· Nanfang Hospital, Southern Medical University· Source

• Active, not recruiting

  Beta-Blockers on Neoadjuvant Immunochemotherapy for Hypertensive Patients With Gastric Cancer

  NCT07622693· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients

  NCT07903454· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

  NCT07539779· Phase 2/3· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

  NCT07450599· Phase 2· Bayer· Source

• Recruiting

  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  NCT07416604· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors

  NCT07759960· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study

  NCT07539792· Phase 2· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms

  NCT07754188· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)

  NCT07707076· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

  NCT07331272· Phase 1· Nanjing Legend Biotech Co.· Source

• Not yet recruiting

  Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

  NCT07231276· Phase 4· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome

  NCT07334873· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue

  NCT07276854· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

  NCT07284134· Phase 3· Shanghai Junshi Bioscience Co., Ltd.· Source

• Recruiting

  Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  NCT07185997· Phase 3· ArriVent BioPharma, Inc.· Source

• Recruiting

  A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors

  NCT07179679· Phase 1· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

• Recruiting

  A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

  NCT07189065· Phase 2· Guangzhou Lupeng Pharmaceutical Company LTD.· Source

• Recruiting

  Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

  NCT07176650· Phase 1· Shanghai Henlius Biotech· Source

• Active, not recruiting

  A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection

  NCT07245953· Phase 2· Suzhou HepaThera Biotech Co., Ltd.· Source

• Recruiting

  PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer

  NCT07775820· Nanfang Hospital, Southern Medical University· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

  NCT07203352· Phase 3· Nanfang Hospital, Southern Medical University· Source

• Not yet recruiting

  A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

  NCT06364904· Phase 3· Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University· Source

• Recruiting

  A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

  NCT07154264· Phase 2· Dizal Pharmaceuticals· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  NCT07091630· Phase 3· argenx· Source

• Recruiting

  Clinical Study of Cizutamig in Systemic Lupus Erythematosus

  NCT07215663· Phase 1· Candid Therapeutics· Source

Showing 50 of 166.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and oesophageal cancer15 recruiting
• Childhood cancers12 recruiting
• Lung cancer9 recruiting
• Acute lymphoblastic leukaemia8 recruiting
• Hepatitis B7 recruiting
• Liver and biliary tract cancer6 recruiting
• Stroke5 recruiting
• Acute myeloid leukaemia4 recruiting
• Chronic kidney disease4 recruiting
• Chronic lymphocytic leukaemia4 recruiting
• Colorectal cancer4 recruiting
• Haemophilia4 recruiting
• Fatty liver disease (MASLD/MASH)3 recruiting
• Head and neck cancer3 recruiting
• High blood pressure3 recruiting
• Immune thrombocytopenia (ITP)3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Bladder cancer2 recruiting
• Brain aneurysm2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Coronary artery disease2 recruiting
• Dermatomyositis and polymyositis (myositis)2 recruiting
• Glaucoma2 recruiting
• Heart failure2 recruiting
• Lupus (SLE)2 recruiting
• Mantle cell lymphoma2 recruiting
• Multiple myeloma2 recruiting
• Myelodysplastic syndromes2 recruiting
• Obstructive sleep apnoea2 recruiting
• Prostate cancer2 recruiting
• Thalassaemia2 recruiting
• Amyloidosis1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• COPD1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Glioblastoma1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• IgA nephropathy1 recruiting
• Kidney cancer1 recruiting
• Liver cirrhosis1 recruiting
• Metastatic breast cancer1 recruiting
• Migraine1 recruiting
• Myasthenia gravis1 recruiting
• Neuroendocrine tumours1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting
• Vitiligo1 recruiting

Closed trials

• Terminated

  A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

  NCT07100938· Phase 2· BeiGene· Source

• Withdrawn

  A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

  NCT06990776· Phase 2· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Terminated

  Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

  NCT06897579· Phase 2· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Completed

  Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

  NCT06848400· Nanfang Hospital, Southern Medical University· Source

• Completed

  Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis

  NCT06869200· Guangdong Hongzhi Health Technology· Source

• Completed

  Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver Tumors

  NCT07745153· Southern Medical University, China· Source

• Completed

  A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

  NCT06439342· Phase 3· Takeda· Source

• Completed

  Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia

  NCT06646146· Nanfang Hospital, Southern Medical University· Source

• Completed

  Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

  NCT06550128· Phase 2· Ausper Biopharma Co., Ltd.· Source

• Completed

  Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity

  NCT06613750· Phase 4· Zhibin Xu· Source

• Completed

  Comparison of a Single Versus Double Perclose Technique for TAVR

  NCT06173115· Second Affiliated Hospital, Zhejiang University, School of Medicine· Source

• Completed

  Optimizing Early Nutrition Support in Severe Stroke-2

  NCT05998902· Phase 3· Wen Jiang-3· Source

• Completed

  China 3T MRI Study

  NCT06038123· Medtronic Cardiac Rhythm and Heart Failure· Source

• Completed

  An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

  NCT06116968· Phase 3· Corxel Pharmaceuticals· Source

• Completed

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

  NCT06353347· Phase 3· Shenzhen HighTide Biopharmaceutical Ltd.· Source

• Completed

  Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

  NCT06350890· Phase 3· Shenzhen HighTide Biopharmaceutical Ltd.· Source

• Completed

  InsightPFA Trial of the LotosPFA Catheter

  NCT06014996· Insight Medtech Co., Ltd.· Source

• Completed

  A Study of Daridorexant in Chinese Patients With Insomnia Disorder

  NCT06010693· Phase 3· Jiangsu Simcere Pharmaceutical Co., Ltd.· Source

• Completed

  A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients

  NCT06115993· Phase 1/2· Ausper Biopharma Co., Ltd.· Source

• Completed

  A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

  NCT05905458· Phase 2· Chengdu Suncadia Medicine Co., Ltd.· Source

• Completed

  A Study of SPH3127 in the Treatment of Mild to Moderate Ulcerative Colitis

  NCT05770609· Phase 2· Shanghai Pharmaceuticals Holding Co., Ltd· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

  NCT06355479· Phase 3· Healthgen Biotechnology Corp.· Source

• Completed

  A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

  NCT05707351· Phase 3· Takeda· Source

• Completed

  JNT Versus TNT to Guided OGT-overlap Oesophagojejunostomy

  NCT06412575· Nanfang Hospital, Southern Medical University· Source

• Completed

  This is a Phase 1 Study in Which Healthy Volunteers and Participants With Chronic HBV Infection Will be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity

  NCT06746311· Phase 1· Suzhou HepaThera Biotech Co., Ltd.· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· Phase 2/3· argenx· Source

• Recruiting

  OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

  NCT05450835· Nanfang Hospital, Southern Medical University· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  NCT05400369· Phase 4· Daiichi Sankyo· Source

• Completed

  A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B

  NCT05365217· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

  NCT05306418· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· Phase 3· Novo Nordisk A/S· Source

• Completed

  Chinese Osteoporotic Fracture Registration Network Platform

  NCT05339425· Peking Union Medical College Hospital· Source

• Completed

  A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A

  NCT05092841· Phase 3· Tasly GeneNet Pharmaceuticals Co., Ltd· Source

• Completed

  Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

  NCT04983043· Phase 2· Tasly Pharmaceutical Group Co., Ltd· Source

• Completed

  A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

  NCT04939142· Phase 3· Antengene Corporation· Source

• Terminated

  To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

  NCT04551053· Phase 3· Incyte Corporation· Source

• Terminated

  To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)

  NCT04551066· Phase 3· Incyte Corporation· Source

• Completed

  Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma

  NCT04849351· Phase 2· Hutchison Medipharma Limited· Source

• Completed

  A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

  NCT04661150· Phase 2· Hoffmann-La Roche· Source

• Completed

  Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

  NCT04662710· Phase 3· Merck Sharp & Dohme LLC· Source

• Completed

  HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

  NCT04694495· Zhujiang Hospital· Source

• Completed

  A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

  NCT04543617· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

  NCT04535544· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source

• Completed

  A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

  NCT04225715· Phase 2· Hoffmann-La Roche· Source

• Completed

  CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies

  NCT04605666· Phase 2· Nanfang Hospital, Southern Medical University· Source

• Completed

  A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  NCT04202003· Phase 1/2· TJ Biopharma Co., Ltd.· Source

• Completed

  Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

  NCT03938792· Phase 3· Pfizer· Source

• Completed

  Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer

  NCT05928299· Nanfang Hospital, Southern Medical University· Source

• Completed

  A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

  NCT04102098· Phase 3· Hoffmann-La Roche· Source

Showing 50 of 57.

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer101 works · 16 trials
• Colorectal cancer96 works · 5 trials
• Chronic kidney disease85 works · 4 trials
• Gastric and oesophageal cancer67 works · 23 trials
• Osteoarthritis42 works · 1 trial
• Acute myeloid leukaemia29 works · 6 trials
• Bladder cancer27 works · 2 trials
• Hepatitis B27 works · 19 trials
• Osteoporosis25 works · 3 trials
• Fatty liver disease (MASLD/MASH)24 works · 5 trials
• Glioblastoma24 works · 1 trial
• Rheumatoid arthritis21 works · 1 trial
• Insomnia21 works · 1 trial
• Lupus (SLE)19 works · 2 trials
• Aortic aneurysm17 works · 0 trials
• Spinal cord injury15 works · 0 trials
• Acute lymphoblastic leukaemia13 works · 9 trials
• IgA nephropathy12 works · 1 trial
• Gout8 works · 0 trials
• Haemophilia8 works · 13 trials
• Thalassaemia7 works · 4 trials
• Brain aneurysm6 works · 2 trials
• Sjögren's disease6 works · 0 trials
• Neuromyelitis optica (NMOSD)5 works · 0 trials
• Chronic myeloid leukaemia5 works · 2 trials
• Aplastic anaemia3 works · 0 trials